Amexdrug Corporation
Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. It is also involved in the research, development, manufacture, and sale of pharmaceutical drugs, cosmetics, and medical devices. The company operates in two segments, Distribution and Health and Beauty Products. In addition, it engages in the distribution of p… Read more
Amexdrug Corporation (AXRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2018: -0.095x
Based on the latest financial reports, Amexdrug Corporation (AXRX) has a cash flow conversion efficiency ratio of -0.095x as of March 2018.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-110.76K) by net assets ($1.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Amexdrug Corporation - Cash Flow Conversion Efficiency Trend (2001–2017)
This chart illustrates how Amexdrug Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Amexdrug Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Amexdrug Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Marine Food Gr
PINK:CMFO
|
-0.008x |
|
STRATEX INTL
BE:S1Y
|
N/A |
|
PROPLASTICS LIMITED
XZIM:PROL
|
N/A |
|
ICFG Limited
LSE:ICFG
|
N/A |
|
INTERNATIONAL ENERGY INSURANCE PLC
XNSA:INTENEGINS
|
N/A |
|
MFM Korea Co. Ltd.
KO:323230
|
N/A |
|
Solartron PCL
STU:TUU
|
0.004x |
|
Inspirit Energy Holdings Plc
LSE:INSP
|
-0.936x |
Annual Cash Flow Conversion Efficiency for Amexdrug Corporation (2001–2017)
The table below shows the annual cash flow conversion efficiency of Amexdrug Corporation from 2001 to 2017.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2017-12-31 | $806.69K | $27.49K | 0.034x | +119.61% |
| 2016-12-31 | $697.60K | $-121.20K | -0.174x | -715.49% |
| 2015-12-31 | $624.77K | $17.64K | 0.028x | -89.59% |
| 2014-12-31 | $525.55K | $142.55K | 0.271x | +172.47% |
| 2012-12-31 | $429.65K | $-160.80K | -0.374x | +4.78% |
| 2011-12-31 | $348.58K | $-137.02K | -0.393x | -143.42% |
| 2010-12-31 | $250.51K | $226.78K | 0.905x | +191.77% |
| 2009-12-31 | $63.60K | $-62.75K | -0.987x | -134.24% |
| 2007-12-31 | $42.00K | $121.00K | 2.881x | -82.54% |
| 2005-12-31 | $10.00K | $165.00K | 16.500x | +2793.88% |
| 2004-12-31 | $-80.00K | $49.00K | -0.613x | +58.02% |
| 2001-12-31 | $-98.00K | $143.00K | -1.459x | -- |